Aristolochic Presence Shows Herbals Web Sales Policy Needed – NEJM Letter
This article was originally published in The Tan Sheet
The continued availability of herbal products containing aristolochic acid via the Internet shows the need for a policy on web sales of dangerous botanical products, according to two members of the Carcinogenic Potency Project, University of California - Berkeley
You may also be interested in...
Herbal products containing aristolochic acids have been linked to reports of kidney failure and will be the subject of an import alert in the near future, FDA says in a May 16 letter to industry.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning